Christopher D. Sarsons
Christopher D. Sarsons publishes mostly in Molecular Biology, Oncology and Biomaterials, on topics such as Protein Degradation and Inhibitors, Nanoparticle-Based Drug Delivery and Chromatin Remodeling and Cancer.
- World rank
- #4,357,835 of 7,710,434 ranked researchers
- Rank in Canada
- #132,954 of 183,316
- Works
- 30
- Citations
- 656
- Citations per work
- 21.9
What does Christopher D. Sarsons research?
Christopher D. Sarsons's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (14%), Materials Science (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1342.5%
- Life Sciences1034.2%
- Health Sciences413.7%
- Medicine413.7%
- Physical Sciences39.6%
- Materials Science25.5%
- Chemistry14.1%
- 1Molecular Biology34% of their works
- 2Oncology6% of their works
- 3Biomaterials6% of their works
- 4Pulmonary and Respiratory Medicine4% of their works
- 5Organic Chemistry4% of their works
- 6Infectious Diseases4% of their works
Research topics
- Protein Degradation and Inhibitors
- Nanoparticle-Based Drug Delivery
- Chromatin Remodeling and Cancer
- Histone Deacetylase Inhibitors Research
- Biological Research and Disease Studies
- Graphene and Nanomaterials Applications
- Gold and Silver Nanoparticles Synthesis and Applications
- Diabetes Treatment and Management
Which keywords describe Christopher D. Sarsons's research?
The keywords of their largest research topics: BET Bromodomains, PROTACs, Biomedical Applications, Cancer Therapy, Drug Delivery, Nanoparticles, Cancer and Nanocarriers.
- Synthetic
- Phosphoethanolamine
- Histone Deacetylases
- Graphene
- Cardiovascular Outcomes
- Chromatin Remodeling
- Nanocarriers
- Nanoparticles
- Cancer Therapy
- PROTACs
- BET Bromodomains
- Biomedical Applications
- Drug Delivery
- Cancer
- Surface Engineering
- SWI/SNF Complexes
- Gold Nanoparticles
- HDAC Inhibitors
- Nanomaterials
- Plasmonic Nanoparticles
- Type 2 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- BET Bromodomains111 topic
- PROTACs111 topic
- Biomedical Applications83 topics
- Cancer Therapy83 topics
- Drug Delivery62 topics
- Nanoparticles62 topics
- Cancer52 topics
- Nanocarriers41 topic
- Surface Engineering41 topic
- Chromatin Remodeling31 topic
- SWI/SNF Complexes31 topic
- Cardiovascular Outcomes21 topic
- Gold Nanoparticles21 topic
- Graphene21 topic
- HDAC Inhibitors21 topic
- Histone Deacetylases21 topic
- Nanomaterials21 topic
- Phosphoethanolamine21 topic
- Plasmonic Nanoparticles21 topic
- Synthetic21 topic
- Type 2 Diabetes21 topic
Where does Christopher D. Sarsons work?
Christopher D. Sarsons's main affiliation in the publication record is Resverlogix (Canada), Canada.
How many publications and citations does Christopher D. Sarsons have?
OpenAlex counts 30 works and 656 citations for Christopher D. Sarsons, an h-index of 10, ranking #4,357,835 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christopher D. Sarsons. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.